Concomitant medications in cancer patients: should we be more active in their management?

Ann Oncol. 2010 Feb;21(2):430. doi: 10.1093/annonc/mdp539. Epub 2009 Nov 25.

Authors

S Lord¹, P S Hall², M T Seymour³

Affiliations

¹ Department of Medical Oncology, St James's Institute of Oncology. Electronic address: s.r.lord@leeds.ac.uk.
² Section of Oncology and Clinical Research, University of Leeds, Leeds, UK.
³ Department of Medical Oncology, St James's Institute of Oncology.

PMID: 19940008
DOI: 10.1093/annonc/mdp539

No abstract available

Publication types

Comment
Letter

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
Antineoplastic Combined Chemotherapy Protocols / adverse effects
Drug Interactions*
Humans
Medical Oncology / methods
Medical Oncology / trends
Models, Theoretical
Neoplasms / drug therapy*
Neoplasms / metabolism
Palliative Care
Polypharmacy*
Practice Guidelines as Topic